Back
29
98
Also listed as
QABSY
OTC
Day Range
$6.10
$6.35
52-Week Range
$4.49
$7.80
Volume
1
50D / 200D Avg
$6.87
/
$6.87
Prev Close
$6.10
Price History
Financial Trends
Peer Comparison
vs Industrials sector median (889 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 5.8 | 9.1 |
| P/B | 11.9 | 2.0 |
| ROE % | 300.8 | 12.9 |
| Net Margin % | 6.9 | 7.9 |
| Rev Growth 5Y % | 40.9 | 8.6 |
| D/E | 10.2 | 0.6 |
Key Takeaways
Revenue grew 40.93% annually over 5 years — strong growth
Earnings grew 27.89% over the past year
ROE of 300.84% indicates high profitability
Debt/Equity of 10.23 — high leverage
Generating 448.00M in free cash flow
P/E of 5.75 — trading at a low valuation
Growth
Revenue Growth (5Y)
40.93%
Revenue (1Y)8.29%
Earnings (1Y)27.89%
FCF Growth (3Y)-57.59%
Quality
Return on Equity
300.84%
ROIC17.53%
Net Margin6.86%
Op. Margin8.72%
Safety
Debt / Equity
10.23
Current Ratio0.36
Interest Coverage7.79
Valuation
P/E Ratio
5.75
P/B Ratio11.86
EV/EBITDA7.34
Dividend Yield0.03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 8.29% | Revenue Growth (3Y) | 8.69% |
| Earnings Growth (1Y) | 27.89% | Earnings Growth (3Y) | -4.12% |
| Revenue Growth (5Y) | 40.93% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 23.41B | Net Income (TTM) | 1.61B |
| ROE | 300.84% | ROA | 6.87% |
| Gross Margin | 54.51% | Operating Margin | 8.72% |
| Net Margin | 6.86% | Free Cash Flow (TTM) | 448.00M |
| ROIC | 17.53% | FCF Growth (3Y) | -57.59% |
| Safety | |||
| Debt / Equity | 10.23 | Current Ratio | 0.36 |
| Interest Coverage | 7.79 | Dividend Yield | 0.03% |
| Valuation | |||
| P/E Ratio | 5.75 | P/B Ratio | 11.86 |
| P/S Ratio | 0.39 | PEG Ratio | 0.23 |
| EV/EBITDA | 7.34 | Dividend Yield | 0.03% |
| Market Cap | 9.23B | Enterprise Value | 14.97B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 23.41B | 21.62B | 19.82B | 9.11B | 5.93B |
| Net Income | 1.61B | 1.26B | 1.75B | -860.00M | -1.73B |
| EPS (Diluted) | 1.04 | 0.75 | 0.93 | -0.46 | -0.92 |
| Gross Profit | 12.76B | 11.46B | 7.00B | 1.91B | 1.57B |
| Operating Income | 2.04B | 1.87B | 6.75B | 1.79B | 1.50B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 23.36B | 20.56B | 20.35B | 19.65B | 17.88B |
| Total Liabilities | 22.57B | 20.27B | 20.34B | 19.84B | 17.36B |
| Shareholders' Equity | 778.00M | 289.00M | 5.00M | -197.00M | 513.00M |
| Total Debt | 7.96B | 6.59B | 6.73B | 7.23B | 8.23B |
| Cash & Equivalents | 2.21B | 1.72B | 3.17B | 3.34B | 2.22B |
| Current Assets | 4.52B | 3.98B | 5.11B | 5.63B | 3.43B |
| Current Liabilities | 12.72B | 11.74B | 12.10B | 10.56B | 7.60B |
Strategy Scores
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
#369 of 612
#4 of 655
Recent Activity
Entered
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
Entered
Contrarian Investing (David Dreman)
Mar 24, 2026